Adults with type 2 diabetes using a GLP-1 drug have a similar risk for thyroid cancer as those using other diabetes drugs, though increased thyroid cancer risk was observed in the first year after GLP-1 initiation, researchers reported. In an analysis of administrative claims data from the OptumLabs Data Warehouse published in JAMA OtolaryngologyâHead & Neck Surgery, researchers found
KOLOA, Hawaii â Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision,…
Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally tolerated it well, according to data published in The Lancet Respiratory…
There is no better place to share your research than ENDO, the Endocrine Society’s annual meeting. Submitting an abstract earns media coverage for your work,…
You’ve successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your…
Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable divergence with the recommended dosages of urate-lowering therapies, according…
Susan Weiner, MS, RDN, CDN, CDCES, FACES, talks with Brenda Jagatic, BScN, RN, CDCES, about the prevalence of erectile dysfunction for men with diabetes and…
KOLOA, Hawaii â In this Healio Video Perspective from Hawaiian Eye 2025, Uday Devgan, MD, this yearâs recipient of the Philip M. Corboy, MD, Memorial…
Sharpen your skills and earn points. Itâs a fun way to test your knowledge through friendly competition with your peers. Learn something new and discover…
The FDA has granted breakthrough therapy designation to Bluejay Therapeuticsâ brelovitug for the treatment of chronic hepatitis delta, for which no approved therapies currently exist…
